NeuroImage. Clinical · 2026
A comparative study of deep learning for cortical lesion MRI segmentation with explainability analysis in multiple sclerosis.
СтатьяСравнительное исследованиеМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Molchanova Nataliia, Cagol Alessandro, Ocampo-Pineda Mario, Lu Po-Jui, Weigel Matthias, Chen Xinjie, Beck Erin S, Tsagkas Charidimos, Reich Daniel S, Bulcke Colin Vanden, Stölting Anna, Borrelli Serena, Maggi Pietro, Lugo Sebastian Baez, Lemay Delphine Ribes, Depeursinge Adrien, Granziera Cristina, Müller Henning, Gordaliza Pedro M, Bach Cuadra Meritxell
Аннотация
Cortical lesions (CLs) have emerged as valuable biomarkers in multiple sclerosis (MS), offering high diagnostic specificity and prognostic relevance. However, their routine clinical integration remains limited due to subtle magnetic resonance imaging (MRI) appearance, challenges in expert annotation, and a lack of standardized automated methods. We present a multi-centric comparative study of CL detection and segmentation in MRI. A total of 656 MRI scans, including clinical trial and research data from four institutions, were acquired at 3T and 7T using MP2RAGE and MPRAGE sequences with expert-consensus annotations. We rely on the self-configuring nnU-Net framework, designed for medical imaging segmentation, and propose adaptations tailored to the improved CL detection. We evaluated model generalization through out-of-distribution testing, demonstrating promising lesion detection capabilities with an F1-score of 0.64 and 0.5 in and out of the domain, respectively. We also analyze internal model features and model errors for a better understanding of AI decision-making. Our study examines how data variability, lesion ambiguity, and protocol differences impact model performance, offering future recommendations to address these barriers to clinical adoption. Furthermore, we designed and implemented a medical expert questionnaire for better assessment of clinical value of the model predictions. To reinforce the reproducibility, the implementation and models will be publicly accessible and ready to use at GitHub and Zenodo.